| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.003 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |